Faculty Disclosures
| Venkatesh Aiyagari, MD |
Dr. Aiyagari has received publishing royalties from a publication relating to health care. |
| David M. Greer, MD, FAAN |
Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. The institution of Dr. Greer has received research support from Becton, Dickinson and Company. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. |
| Janice M. Massey, MD, FAAN |
Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenix. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance Therapeutics. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta. The institution of Dr. Massey has received research support from Revance . |
| Hamza I. Maqsood, MD |
Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. |
| Stephan A. Mayer, MD |
Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phagenesis. Dr. Mayer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astra Zeneca. Dr. Mayer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Mayer has stock in Neuroptics. Dr. Mayer has received publishing royalties from a publication relating to health care. |
| Vern C. Juel, MD, FAAN |
Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Accordant Health Services. Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Dr. Juel has received research support from argenx. The institution of Dr. Juel has received research support from Alexion. The institution of Dr. Juel has received research support from Janssen. The institution of Dr. Juel has received research support from NIH Rare Diseases Network. |
| William J. Powers, MD, FAAN |
Dr. Powers has a non-compensated relationship as a Chair of the Writing Group for Acute Ischemic Stroke Guidelines with American Heart Association that is relevant to AAN interests or activities. |
| Michael N. Diringer, MD |
No disclosure on file
|
| J. Javier Provencio, MD, FAAN |
Dr. Provencio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Minnetronix. The institution of Dr. Provencio has received research support from NIH NINDS. |
| Minal Bhanushali, MD |
No disclosure on file
|
| Richard M. Ransohoff, MD |
Dr. Ransohoff has received personal compensation for serving as an employee of Third Rock Ventures. Dr. Ransohoff has stock in Biogen. Dr. Ransohoff has received intellectual property interests from a discovery or technology relating to health care. |
| Allyson Zazulia |
An immediate family member of Dr. Zazulia has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical Care Society. |
|
No disclosure on file
|
| William M. Coplin, MD, FCCM |
No disclosure on file
|
| Angelo Ghezzi, MD |
No disclosure on file
|
| Maria A. Rocca |
Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla. |
| Bruno Colombo |
Bruno Colombo has nothing to disclose. |
| Jennifer A. Frontera, MD |
Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FirstKindMedical. Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Physician 好色先生 Resource. The institution of Dr. Frontera has received research support from NIH. The institution of Dr. Frontera has received research support from Alexion. Dr. Frontera has received publishing royalties from a publication relating to health care. |
| Jan Claassen, MD, PhD |
Dr. Claassen has stock in iCE Neurosystems. The institution of Dr. Claassen has received research support from NINDS. The institution of Dr. Claassen has received research support from McDonnel Foundation. Dr. Claassen has received publishing royalties from a publication relating to health care. Dr. Claassen has received publishing royalties from a publication relating to health care. |
| Andres Fernandez, MD |
No disclosure on file
|
| Katja E. Wartenberg, MD |
No disclosure on file
|
| Fred Rincon, MD |
Dr. Rincon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeuroCrit, LLC. Dr. Rincon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for NeuroCrit, LLC. |
| Mustapha A. Ezzeddine, MD, FAAN |
The institution of Dr. Ezzeddine has received research support from NIH. |
| Steven R. Messe, MD, FAHA, FAAN |
Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Terumo. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for WL Gore. The institution of Dr. Messe has received research support from WL Gore. The institution of Dr. Messe has received research support from Mallinkrodt. The institution of Dr. Messe has received research support from Biogen. Dr. Messe has received intellectual property interests from a discovery or technology relating to health care. Dr. Messe has received publishing royalties from a publication relating to health care. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving as a Clinical Event Committee for the CONFORMAL left atrial appendage occlusion trial with Yale Cardiovascular Research Group. |
| Scott E. Kasner, MD, FAAN |
Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Diamedica. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Javelin. Dr. Kasner has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Kasner has received research support from Bristol-Myers Squibb. The institution of Dr. Kasner has received research support from Medtronic. The institution of Dr. Kasner has received research support from WL Gore. |
| Olli P. Happola, MD, PhD |
No disclosure on file
|
| Mikko Kallela, MD |
No disclosure on file
|
| Perttu J. Lindsberg, MD |
The institution of Dr. Lindsberg has received research support from Helsinki University Hospital District. The institution of Dr. Lindsberg has received research support from Sigrid Juselius foundation. |
| Markku Kaste, MD, PhD |
No disclosure on file
|
| Alfredo Thomson, MD |
Dr. Thomson has nothing to disclose. |
| Nabila Dahodwala, MD, FAAN |
Dr. Dahodwala has received personal compensation in the range of $0-$499 for serving as a Consultant for Genetech. Dr. Dahodwala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mediflix. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Post and Schell. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for O'Brien & Ryan, LLP. The institution of Dr. Dahodwala has received research support from AbbVie. The institution of Dr. Dahodwala has received research support from Medtronic. |
| Kimberly L. Panizzon |
No disclosure on file
|
| Roi A. Wallis, MD |
No disclosure on file
|
| Gustavo J. Rodriguez, MD |
Dr. Rodriguez has nothing to disclose. |
| Tania Giovannetti |
No disclosure on file
|
| Allie M. Massaro, MD |
No disclosure on file
|
| Sheryl Martin-Schild, MD, PhD, FAAN |
No disclosure on file
|
| Digvijaya D. Navalkele, MD |
Dr. Navalkele has nothing to disclose. |
| Jose L. Torres, MD |
Dr. Torres has nothing to disclose. |
| Hsinlin T. Cheng, MD |
Dr. Cheng has nothing to disclose. |
| Fabio Adrian Barroso, MD |
Fabio Adrian Barroso, MD has nothing to disclose. |
| Seung-Han Suk, MD |
No disclosure on file
|
| Dennis Parker Jr. |
No disclosure on file
|
| Kumar Rajamani, MD, FAAN |
Dr. Rajamani has nothing to disclose. |
| Shishir K. Rao, MD |
The institution of Dr. Rao has received research support from Eisai, Inc. |
| Kavita Sail, PhD |
No disclosure on file
|
| Wazim Mohamed, MD |
Dr. Mohamed has nothing to disclose. |
| Kushak Suchdev, MD |
Dr. Suchdev has nothing to disclose. |
| Lucia Moiola, MD, PhD |
Dr. Moiola has nothing to disclose. |
| Yash Jalundhwala, PhD |
Dr. Jalundhwala has received personal compensation for serving as an employee of AbbVie . An immediate family member of Dr. Jalundhwala has received personal compensation for serving as an employee of AbbVie . Dr. Jalundhwala has received stock or an ownership interest from AbbVie. |
| Agustina Tamargo |
No disclosure on file
|
| Laura Vacchi |
No disclosure on file
|
| Jose Pastor-Rueda |
No disclosure on file
|
| Rudolph E. Tanzi, PhD |
No disclosure on file
|
| Lucas Alessandro, Sr., MD |
Dr. Alessandro has nothing to disclose. |
| David A. Wolk, MD, FAAN |
Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Functional Neuromodulation. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. The institution of Dr. Wolk has received research support from Biogen. Dr. Wolk has received publishing royalties from a publication relating to health care. Dr. Wolk has received personal compensation in the range of $5,000-$9,999 for serving as a CME speaker with Eli Lilly. |
| Jeff Guptill, MD, FAAN |
Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has stock in argenx. |
| Thomas Marshall, PharmD |
No disclosure on file
|
| Jorge J. Pesquera, MD |
No disclosure on file
|
| Catalina Bensi |
No disclosure on file
|
| Guido D. Vazquez II, PhD |
Dr. Vazquez has nothing to disclose. |
| Maria Palmeri |
Ms. Palmeri has nothing to disclose. |